Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
HALO | HALOZYME THERAPEUTICS, INC. | Director | $896K | Aug 11, 2023 | ||
ACAD | ACADIA PHARMACEUTICALS INC | Director | $577K | May 29, 2024 | ||
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Director | $535K | -$8.22M | -93.9% | Jun 25, 2024 |
BLCM | BELLICUM PHARMACEUTICALS, INC | Director | $21.6K | Jan 3, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|